Viewing Study NCT02965092


Ignite Creation Date: 2025-12-24 @ 3:07 PM
Ignite Modification Date: 2026-02-03 @ 1:18 AM
Study NCT ID: NCT02965092
Status: UNKNOWN
Last Update Posted: 2019-05-10
First Post: 2016-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies
Sponsor: Wuhan Sian Medical Technology Co., Ltd
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-12-02
Start Date Type: ACTUAL
Primary Completion Date: 2021-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2021-12
Completion Date Type: ESTIMATED
First Submit Date: 2016-11-13
First Submit QC Date: None
Study First Post Date: 2016-11-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-05-08
Last Update Post Date: 2019-05-10
Last Update Post Date Type: ACTUAL